Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “H3N2 Influenza”

34 trials

Showing 20 of 34 results

Early research (Phase 1)Study completedNCT04372719
What this trial is testing

Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers

Who this might be right for
Influenza, Human
SGS Life Sciences, a division of SGS Belgium NV 36
Early research (Phase 1)Study completedNCT06476275
What this trial is testing

Single Dose Texas 2017 (H3N2) Challenge Study

Who this might be right for
Influenza Viral Infections
Duke University 33
Not applicableStudy completedNCT01459276
What this trial is testing

Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 1,206
Testing effectiveness (Phase 2)Study completedNCT03883113
What this trial is testing

Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model

Who this might be right for
Influenza
Barinthus Biotherapeutics 145
Early research (Phase 1)Study completedNCT01498718
What this trial is testing

Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 131
Post-approval studies (Phase 4)Study completedNCT01246999
What this trial is testing

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Who this might be right for
Influenza
University of Rochester 34
Not applicableLooking for participantsNCT06620185
What this trial is testing

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

Who this might be right for
Influenza
Imperial College London 36
Early research (Phase 1)Study completedNCT03553940
What this trial is testing

H3N2 M2SR in Pediatric Population

Who this might be right for
InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 43
Not applicableStudy completedNCT06972810
What this trial is testing

Human Infection Study of H3N2 Influenza in Healthy Adults

Who this might be right for
Influenza
University of Melbourne 11
Early research (Phase 1)Study completedNCT04785794
What this trial is testing

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Who this might be right for
Influenza Vaccine
FluGen Inc 122
Early research (Phase 1)Study completedNCT02822105
What this trial is testing

Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers

Who this might be right for
Flu
FluGen Inc 96
Not applicableStudy completedNCT04204993
What this trial is testing

Assessment of Wearable Sensors During Experimental Human Influenza Infection (Sigma Plus)

Who this might be right for
Influenza A H3N2
Imperial College London 20
Early research (Phase 1)Study completedNCT03999554
What this trial is testing

Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines

Who this might be right for
Influenza A
FluGen Inc 206
Post-approval studies (Phase 4)Study completedNCT03540823
What this trial is testing

Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases

Who this might be right for
Systemic LupusSjogren's Syndrome
University of Sao Paulo General Hospital 300
Early research (Phase 1)Study completedNCT04978454
What this trial is testing

Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT01408290
What this trial is testing

Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 256
Testing effectiveness (Phase 2)Study completedNCT03220048
What this trial is testing

Study Examining PrEP-001 in Healthy Subjects

Who this might be right for
Influenza A H3N2
Hvivo 66
Testing effectiveness (Phase 2)Study completedNCT03315104
What this trial is testing

Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

Who this might be right for
Influenza A H3N2Influenza A H1N1
Emergent BioSolutions 65
Post-approval studies (Phase 4)UnknownNCT02232945
What this trial is testing

Banlangen Granules Anti-seasonal Influenza Study

Who this might be right for
Influenza
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited 177
Large-scale testing (Phase 3)Study completedNCT06087640
What this trial is testing

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Who this might be right for
Influenza, Human
Seqirus 38,769
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation